FATE THERAPEUTICS INC — Director's Dealing 2016

Aug 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-08-23

Reporting Person: Wolchko J Scott (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-23	Common Stock	M	2570	$1.37	Acquired	142049	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-23	Stock Option (right to buy)	$1.37	M	2570	Disposed	2022-07-23	Common Stock (2570)	Direct

Footnotes

F1: The shares subject to this option became fully vested and exercisable on July 3, 2016.

F2: Not applicable.